+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-01-27Number of Pages: 98

Oxygen Therapy Devices Market (Product Type - Oxygen Source Equipment and Oxygen Delivery Devices; Application - Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, and Pneumonia) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Global Oxygen Therapy Devices Market: Snapshot 

The prevalence of chronic respiratory diseases such as asthma, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), occupational lung disease, and respiratory allergies has been increasing worldwide, especially in middle-income and low-income countries. The World Health Organization states that each year, at least 3 million people die from COPD. This alarming rise in the prevalence of various respiratory diseases is the primary factor boosting the uptake of oxygen therapy and oxygen therapy devices. The global market for oxygen therapy devices is expected to value US$2.8 bn by 2020, the end of the forecast period. The numerous benefits of oxygen therapy will also contribute to the growth of this market. These include reduced risk of heart failure, better mental stamina, and enhanced breathing patterns. 

Liquid Oxygen Devices Gain Much Traction thanks to Greater Storage Capacity 

On the basis of product type, the oxygen therapy devices market has been bifurcated into oxygen source equipment and oxygen delivery devices. Cylinders, concentrators, and liquid oxygen devices are the main types of oxygen source equipment, of which, oxygen concentrators hold the leading share in the overall market. Nevertheless, liquid oxygen devices will register strong growth in the coming years owing to their rising application in the treatment of different respiratory disorders and greater storage capacity. Oxygen delivery devices include nasal cannula, Venturi masks, bag valve masks, non-rebreather masks, simple oxygen masks, and continuous positive airway pressure (CPAP) masks. Among these, Venturi masks are likely to witness higher growth through 2020. 

Oxygen therapy devices find application in the treatment of asthma, chronic obstructive pulmonary disease (COPD), respiratory distress syndrome, pneumonia, obstructive sleep apnea, and cystic fibrosis. The COPD segment dominates the overall oxygen therapy devices market and is anticipated to retain its hold throughout the forecast period on account of increasing prevalence of COPD and a rising number of patients showing preference for oxygen therapy as the first treatment option. 

North America to Retain Lead in Global Oxygen Therapy Devices Market 

By way of region, the global market for oxygen therapy devices has been segmented into Asia Pacific, North America, Europe, and Rest of the World. North America accounted for the dominant share at the start of the forecast period and is slated to continue its leading streak through 2020. This can be attributed to factors such as superior and sophisticated healthcare infrastructure, constant technological advancement in the field of medical devices, and growing awareness among the patient population. Rising prevalence of various life-threatening respiratory diseases is also a major factor boosting the demand for and usage of oxygen therapy devices in North America. The National Institutes of Health states that chronic obstructive pulmonary disease – the third leading cause of death in the U.S. – claims over 120,000 lives each year. This alarming prevalence of COPD is sure to keep the demand for oxygen therapy devices high in the region. 

Asia Pacific, on the other hand, will be one of the most promising regions in the global market and is slated to witness impressive growth over the coming years. Factors such as a large population base, rapid economic growth, improving awareness among consumers regarding personal health and wellbeing, rising promotional initiatives by the government, and better disease management are likely to give the Asia Pacific oxygen therapy devices market a significant boost. 

AirSep Corporation, Philips Respironics, Inc., MAQUET Holding B.V. & Co. KG, ResMed, CareFusion Corporation, Teleflex Incorporated,Smiths Medical, Invacare Corporation, Fisher and Paykel Healthcare Limited, and DeVilbiss Healthcare LLC are some of the leading contributors in the global oxygen therapy devices market are 

Description: 

Oxygen therapy is a treatment that provides extra oxygen to lungs whenever a disease or respiratory condition is preventing them from getting enough oxygen. It is gaining popularity as one of the most reliable options used for the treatment of numerous types of respiratory diseases due to its supplementary, palliative, and definitive role. The administration of supplemental oxygen has become imperative for accurate management of various diseases. According to the National Institute of Health, oxygen therapy can potentially enhance the quality and length of life of individuals affected with chronic obstructive pulmonary diseases (COPD). Some of the benefits of this therapy are improved breathing pattern, increased mental stamina, and reduced risks of heart failure in people with severe respiratory disorders. The rising awareness regarding its benefits is fuelling the growth of the global oxygen therapy devices market. 

The report serves as a repository of analysis and information regarding various aspects of the global oxygen therapy devices market including value chain analysis, market dynamics, geographical segmentation, and competitive landscape. Historical data and current market scenario have been taken into account to derive the future trends anticipated in the market. 

Overview of the Global Oxygen Therapy Devices Market 

The increasing adoption of oxygen therapies as a treatment for various diseases including asthma, COPD, obstructive sleep apnea, and respiratory distress syndrome is driving the global oxygen therapy devices market. However, the shortage of proper reimbursement policies and presence of stringent regulations associated with oxygen therapy devices are likely to impede the growth of the market. 

The valuation of the global oxygen therapy devices market was US$1.9 bn in 2013 and is anticipated to rise to US$2.8 bn by 2020, expanding at a CAGR of 5.70% between 2014 and 2020. Geographically, North America was the leading market in terms of revenue in 2013. The growth of this region can be attributed to factors such as rising prevalence of life-threatening respiratory disorders, technological developments in the field of medical devices, increasing awareness regarding the benefits of oxygen therapy, and the presence of well-developed healthcare infrastructure. However, due to the presence of a large population, robust economic growth, and increasing government initiatives to promote healthcare, Asia Pacific is expected to exhibit a significant CAGR over the forecast period. 

On the basis of applications, the market is segmented into asthma, cystic fibrosis, chronic obstructive pulmonary disease, pneumonia, obstructive sleep apnea, and respiratory distress syndrome. The COPD segment will continue to dominate the market until 2020 owing to the increasing incidence of COPD across the globe and rising patient preference for oxygen therapy as their first treatment option. 

On the basis of product type, the market is categorized into two major segments: oxygen delivery devices and oxygen source equipment. The oxygen delivery devices segment is further segmented into bag valve masks, nasal cannula, CPAP masks, non-rebreather masks, and venturi masks. Out of these, venturi masks will dominate the market throughout the forecast period. The sub-segments of oxygen source equipment are liquid oxygen devices, oxygen concentrators, and oxygen cylinders. The liquid devices segment is estimated to rise at a noteworthy CAGR during the same period owing to the increasing need for improved storage capacity and greater mobility and its growing adoption for the treatment of various respiratory diseases. 

Companies Mentioned in the Global Oxygen Therapy Devices Market 

Some of the key players operating in the market are AirSep Corporation, CareFusion Corporation, Fisher & Paykel Healthcare Limited, DeVilbiss Healthcare, Invacare Corporation, MAQUET Holding B.V. & Co. KG, ResMed Inc., Respironics, Inc. (a Philips company), and Teleflex Incorporated. 

The global oxygen therapy devices market is segmented as follows: 

Oxygen Therapy Devices Market, by Product Type

  • Oxygen Source Equipment
    • Oxygen Cylinders
    • Oxygen Concentrators
    • Liquid Oxygen Devices
  • Oxygen Delivery Devices
    • Simple Oxygen Mask
    • Nasal Cannula
    • Venturi Mask
    • Non-rebreather Mask
    • Bag Valve mask
    • CPAP Mask

Oxygen Therapy Devices Market, by Applications

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma 
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome (RDS)
  • Cystic Fibrosis
  • Pneumonia

Oxygen Therapy Devices Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW) 

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 


 
 
Back To Top